Peter Brossart
Overview
Explore the profile of Peter Brossart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
273
Citations
5180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Neuerburg C, Schmitz F, Schmitz M, Rehnelt S, Schumacher M, Parcina M, et al.
Transplant Cell Ther
. 2024 Sep;
30(12):1195.e1-1195.e13.
PMID: 39299503
Background: Prophylactic antibiotics are still controversial during allogeneic hematopoietic stem cell transplantation (allo-HSCT). In our transplant center, we suspended antibiotic prophylaxis during allo-HSCT in 2017. Objective: The main objective of...
12.
Klein C, Jansen F, Brossart P, Herling M, Feldmann G
Case Rep Hematol
. 2024 Sep;
2024:4303614.
PMID: 39228413
T-prolymphocytic leukaemia (T-PLL) is the most common mature T-cell leukaemia in Central Europe and is often manifested by rapidly increasing lymphocytosis, marked bone marrow infiltration and splenomegaly. In 10-15% of...
13.
Klein C, Heine A, Brossart P, Karakostas P, Schafer V
Rheumatol Int
. 2024 Aug;
44(10):2185-2196.
PMID: 39190200
Since the introduction of mRNA vaccines against SARS-CoV-2, the induction of autoimmunity by mRNA vaccination has been discussed. Several cases of dermatomyositis (DM) associated with mRNA vaccination against SARS-CoV-2 infection...
14.
Schafer V, Winter L, Skowasch D, Bauer C, Pizarro C, Weber M, et al.
Rheumatol Int
. 2024 Aug;
44(10):1975-1986.
PMID: 39167172
Objectives: This cross-sectional study aimed to determine the prevalence, manifestation, and risk factors of pulmonary involvement in newly diagnosed, untreated rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients, and to...
15.
Brandenburg A, Heine A, Brossart P
Trends Cancer
. 2024 Jul;
10(8):749-769.
PMID: 39048489
Therapeutic cancer vaccines have been a subject of research for several decades as potential new weapons to tackle malignancies. Their goal is to induce a long-lasting and efficient antitumour-directed immune...
16.
Marinova M, Khouri D, Kuppers J, Ramig O, Strunk H, Breuers J, et al.
J Clin Med
. 2024 Jul;
13(13).
PMID: 38999283
Background: Pancreatic adenocarcinoma (PaC) still has a dismal prognosis, and despite medical advances, a bleak 5-year survival rate of only 8%, largely due to late diagnosis and limited curative surgical...
17.
Kleemiss M, Muller C, Schneider M, Strotmann R, Orlowski K, Goteti K, et al.
Clin Lung Cancer
. 2024 Jul;
25(6):577-580.
PMID: 38987049
No abstract available.
18.
Mispelbaum R, Hattenhauer T, Bauernfeind F, Lau J, Brossart P, Heine A
Front Oncol
. 2024 Jun;
14:1406616.
PMID: 38915369
In the setting of metastatic adrenocortical cancer, there are limited therapy options such as mitotane and platinum-based chemotherapy with only low response rates. Ipilimumab and nivolumab are approved for several...
19.
Wang X, Breuer J, Garbe S, Giordano F, Brossart P, Feldmann G, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892436
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest of human malignancies and carries an exceptionally poor prognosis. It is mostly driven by multiple oncogenic alterations, with the highest mutation...
20.
Petzinna S, Burg L, Bauer C, Karakostas P, Terheyden J, Behning C, et al.
Rheumatology (Oxford)
. 2024 May;
63(9):2379-2386.
PMID: 38759118
Objectives: The objective of this study was to prospectively evaluate the diagnostic efficacy of transorbital ultrasound (TOS) in patients newly diagnosed with giant cell arteritis (GCA), presenting with visual symptoms....